Madrigal Pharmaceuticals (MDGL) had the highest return between August 1, 2017 and October 1, 2017 by a US stock with a market cap of $2B+, returning 190.2%.
| ASSET | DATE | % RETURN |
|---|---|---|
Madrigal Pharmaceuticals (MDGL) | 8/1/2017 - 10/1/2017 | 190.19% |
Insmed (INSM) | 8/1/2017 - 10/1/2017 | 92.18% |
Viking Therapeutics (VKTX) | 8/1/2017 - 10/1/2017 | 85.44% |
Vericel Corp Ord (VCEL) | 8/1/2017 - 10/1/2017 | 84.62% |
Roku (ROKU) | 8/1/2017 - 10/1/2017 | 68.19% |
Enphase Energy (ENPH) | 8/1/2017 - 10/1/2017 | 63.44% |
Leonardo DRS, Inc Common Stock (DRS) | 8/1/2017 - 10/1/2017 | 61.61% |
Skyline (SKY) | 8/1/2017 - 10/1/2017 | 61.2% |
Natera (NTRA) | 8/1/2017 - 10/1/2017 | 58.74% |
Freedom (FRHC) | 8/1/2017 - 10/1/2017 | 56.86% |
Corcept Therapeutics (CORT) | 8/1/2017 - 10/1/2017 | 54.4% |
Celsius (CELH) | 8/1/2017 - 10/1/2017 | 53.51% |
RadNet (RDNT) | 8/1/2017 - 10/1/2017 | 50% |
Abercrombie & Fitch (ANF) | 8/1/2017 - 10/1/2017 | 48.52% |
Stellantis (STLA) | 8/1/2017 - 10/1/2017 | 47.16% |
BeiGene (ONC) | 8/1/2017 - 10/1/2017 | 45.43% |
Appian (APPN) | 8/1/2017 - 10/1/2017 | 44.98% |
Centrais Electricas Brasileiras (EBR) | 8/1/2017 - 10/1/2017 | 44.52% |
AeroVironment (AVAV) | 8/1/2017 - 10/1/2017 | 43.36% |
Protagonist Therapeutics (PTGX) | 8/1/2017 - 10/1/2017 | 42.04% |
Grupo Financiero Galicia SA ADR (GGAL) | 8/1/2017 - 10/1/2017 | 41.56% |
Alnylam Pharmaceuticals (ALNY) | 8/1/2017 - 10/1/2017 | 40.89% |
Riot Blockchain (RIOT) | 8/1/2017 - 10/1/2017 | 40.22% |
Micron Technology (MU) | 8/1/2017 - 10/1/2017 | 39.37% |
Appfolio (APPF) | 8/1/2017 - 10/1/2017 | 36.8% |
